Page 34 - Ram Prasad Sahu/undefined

Tipping point for realty sector: Room for double-digit growth in FY23

Price hikes, market-share gains have helped beat cost pressures, gain volumes

Sun TV rerating rests on capital allocation spin, maintaining ad revenue

IPL valuation bump-up limits downside in stock

Gland Pharma rides high on valuation comfort, strong growth prospects

Target prices post brokerage upgrades point to more upsides

Pidilite Industries stock gains on sales growth, margin recovery hopes

Easing raw material prices are a key trigger for the adhesive market leader

Cost turbulence, rising competition may put pressure on airline stocks

Price hikes may plague demand, robust passenger traffic notwithstanding

Strong domestic outlook remains key growth driver for Torrent Pharma

Cost savings could drive Torrent Pharma's margins higher in the near term

Near-term growth challenges to weigh on Tata Communications stock

Higher investments may cap margins in the near term

Refrigerator import ban, volume recovery can help Whirlpool stay cool

Given raw material pressure, margin trend is another factor

Stock in the green, strong order momentum to power gains for Siemens

Product mix, operating leverage, and price hikes to help expand margins

Revival of orders to boost project business, drive gains for Siemens

Siemens' product mix, operating leverage and price hikes to help expand margins.

Amid margin worries, Jubilant stock to face downside pressure in near term

Aggressive expansion, raw material inflation, and competitive pressures to hit Quick Service Restaurant (QSR) player Jubilant FoodWorks stocks and profitability, say analysts

Bharat Forge's underperformance may continue as truck orders keep low

Uncertainty on revival of demand is a key overhang for the stock

TVS Motor Company buoyant on hopes of volume and margin expansion

Plans in EV space is another trigger; but investors should await better entry point

Execution key as Bata India eyes expansion, change in product mix

The company has been underperforming peers on the growth front over the FY19-22 period

Strong utility vehicle growth trajectory to drive M&M's FY23 performance

Revival in tractors, improvement in supply, and margin gains are other key triggers for the auto major

Near-term growth issues and cost pressure could impact Aurobindo Pharma

While valuations are now attractive, product approvals and progress on the injectable guidance are among key long-term term triggers

A gradual improvement in margins could delay gains for United Spirits

Most analysts are positive on the popular segment sale and premiumisation focus

Near-term growth and cost challenges to weigh on Aurobindo Pharma stock

While valuations are now attractive, product approvals and progress on the injectable guidance are among key long term term triggers

Higher volume growth trajectory key for reversal of Colgate's fortunes

Banking on relaunches, foray into new segments, digital strategy to address issues

Near-term outlook prescription for diagnostic firms looks fragile

Competitive pressures, high valuations limit upsides for listed lab chains